Literature DB >> 21445551

Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy.

Mark W Hull1, Julio Montaner.   

Abstract

Transmission of HIV is critically dependent on the level of HIV viral load within blood and genital secretions. Antiretroviral therapy results in sustained reductions in viral load to undetectable levels. Thus, antiretroviral therapy has long been postulated as a potential means to curb HIV transmission. Observational data have now confirmed that antiretroviral therapy is associated with a decrease in transmission among heterosexual serodiscordant couples, injection-drug users, and in population-based studies. Mathematical models suggest that further expansion of antiretroviral coverage within current guidelines can play a major role in controlling the spread of HIV. Concerns regarding the potential for transmission during acute HIV infection, behavioral disinhibition, and resistance to overcome the impact of treatment on prevention have not materialized to date. The Joint United Nations AIDS (UNAIDS) program has called for the inclusion of antiretroviral treatment as a key pillar in the global strategy to control the spread of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445551     DOI: 10.1007/s11904-011-0076-6

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  56 in total

Review 1.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?

Authors:  J X Velasco-Hernandez; H B Gershengorn; S M Blower
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

4.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.

Authors:  Jairam R Lingappa; Jared M Baeten; Anna Wald; James P Hughes; Katherine K Thomas; Andrew Mujugira; Nelly Mugo; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; James Kiarie; Carey Farquhar; Grace John Stewart; Joseph Makhema; Myron Essex; Edwin Were; Kenneth H Fife; Guy de Bruyn; Glenda E Gray; James A McIntyre; Rachel Manongi; Saidi Kapiga; David Coetzee; Susan Allen; Mubiana Inambao; Kayitesi Kayitenkore; Etienne Karita; William Kanweka; Sinead Delany; Helen Rees; Bellington Vwalika; Amalia S Magaret; Richard S Wang; Lara Kidoguchi; Linda Barnes; Renee Ridzon; Lawrence Corey; Connie Celum
Journal:  Lancet       Date:  2010-02-12       Impact factor: 79.321

5.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

6.  Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.

Authors:  Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey
Journal:  AIDS       Date:  2008-05-11       Impact factor: 4.177

7.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

8.  Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.

Authors:  Anne-Geneviève Marcelin; Roland Tubiana; Sidonie Lambert-Niclot; Gilles Lefebvre; Stéphanie Dominguez; Manuela Bonmarchand; Daniele Vauthier-Brouzes; Françoise Marguet; Nathalie Mousset-Simeon; Gilles Peytavin; Catherine Poirot
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

Review 9.  Behavioural strategies to reduce HIV transmission: how to make them work better.

Authors:  Thomas J Coates; Linda Richter; Carlos Caceres
Journal:  Lancet       Date:  2008-08-05       Impact factor: 79.321

10.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

Authors:  Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  BMJ       Date:  2009-04-30
View more
  13 in total

Review 1.  Treatment as prevention--where next?

Authors:  Mark Hull; Joep Lange; Julio S G Montaner
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

2.  Description and Demonstration of Cognitive Behavioral Therapy to Enhance Antiretroviral Therapy Adherence and Treat Depression in HIV-Infected Adults.

Authors:  Michael E Newcomb; C Andres Bedoya; Aaron J Blashill; Jonathan A Lerner; Conall O'Cleirigh; Megan M Pinkston; Steven A Safren
Journal:  Cogn Behav Pract       Date:  2015-11-01

3.  Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.

Authors:  Steven A Safren; Conall M O'Cleirigh; Jacqueline R Bullis; Michael W Otto; Michael D Stein; Mark H Pollack
Journal:  J Consult Clin Psychol       Date:  2012-04-30

4.  HIV treatment as prevention: the key to an AIDS-free generation.

Authors:  Mark W Hull; Julio S G Montaner
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

Review 5.  Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations.

Authors:  Aimee N C Campbell; Susan Tross; Donald A Calsyn
Journal:  Soc Work Public Health       Date:  2013

6.  Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation.

Authors:  Khaled M Hosny
Journal:  Int J Nanomedicine       Date:  2019-11-01

7.  Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia.

Authors:  Birhanu Waju; Lamessa Dube; Muktar Ahmed; Semira Shimeles Assefa
Journal:  HIV AIDS (Auckl)       Date:  2021-05-14

8.  Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research.

Authors:  David E Vance
Journal:  ISRN Nurs       Date:  2013-02-03

9.  Antiretroviral drugs: critical issues and recent advances.

Authors:  Mira Desai; Geetha Iyer; R K Dikshit
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

10.  Efficacy of a Small-Group Intervention for Post-Incarcerated Black Men Who Have Sex with Men and Women (MSMW).

Authors:  Nina T Harawa; Heather Guentzel-Frank; William Jason McCuller; John K Williams; Gregorio Millet; Lisa Belcher; Heather A Joseph; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2018-04       Impact factor: 5.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.